Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BERT: Temsirolimus with Bendamustine and Rituximab in Relapsed FL or MCL
NCT01078142Phase 2Completed
- Start
- Feb 2010
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in follicular lymphoma (FL), mantle cell lymphoma (MCL). Started Feb 2010; status: completed.
02
Drugs
temsirolimus
03
Conditions
follicular lymphoma (FL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01078142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078142.